Galapagos N.V.

Galapagos N.V.verified

GLPG

Price:

$31.77

Market Cap:

$1.79B

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fib...[Read more]

Industry

Biotechnology

IPO Date

2012-02-27

Stock Exchange

NASDAQ

Ticker

GLPG

The PE Ratio as of December 2025 (TTM) for Galapagos N.V. (GLPG) is -4.05

According to Galapagos N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -4.05. This represents a change of -295.54% compared to the average of 2.07 of the last 4 quarters.

Galapagos N.V. (GLPG) Historical PE Ratio (quarterly & annually)

How has GLPG PE Ratio performed in the past?

The mean historical PE Ratio of Galapagos N.V. over the last ten years is -9.08. The current -4.05 PE Ratio has changed 4.36% with respect to the historical average. Over the past ten years (40 quarters), GLPG's PE Ratio was at its highest in in the June 2023 quarter at 120.69. The PE Ratio was at its lowest in in the June 2016 quarter at -153.69.

Quarterly (TTM)
Annual

Average

-9.08

Median

-14.65

Minimum

-143.48

Maximum

71.71

Galapagos N.V. (GLPG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Galapagos N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 331.12%

Maximum Annual PE Ratio = 71.71

Minimum Annual Increase = -396.66%

Minimum Annual PE Ratio = -143.48

Quarterly (TTM)
Annual
YearPE RatioChange
202423.59104.92%
202311.51-192.37%
2022-12.46-51.52%
2021-25.7052.64%
2020-16.84-123.48%
201971.71-149.98%
2018-143.48331.12%
2017-33.28-164.55%
201651.56-396.66%
2015-17.38-223.86%

Galapagos N.V. (GLPG) Average PE Ratio

How has GLPG PE Ratio performed in the past?

The current PE Ratio of Galapagos N.V. (GLPG) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

7.55

5-year avg

-3.98

10-year avg

-9.08

Galapagos N.V. (GLPG) PE Ratio vs. Peers

How is GLPG’s PE Ratio compared to its peers?

Galapagos N.V.’s PE Ratio is greater than Arcus Biosciences, Inc. (-7.71), greater than Ocular Therapeutix, Inc. (-9.16), greater than ImmunityBio, Inc. (-6.25), greater than Viridian Therapeutics, Inc. (-7.70), greater than Cogent Biosciences, Inc. (-15.84), greater than Denali Therapeutics Inc. (-6.95), greater than uniQure N.V. (-5.66), greater than 89bio, Inc. (-5.20), less than Structure Therapeutics Inc. (-3.52), greater than Mesoblast Limited (-26.59),

Build a custom stock screener for Galapagos N.V. (GLPG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galapagos N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galapagos N.V. (GLPG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galapagos N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Galapagos N.V.'s PE Ratio?

How is the PE Ratio calculated for Galapagos N.V. (GLPG)?

What is the highest PE Ratio for Galapagos N.V. (GLPG)?

What is the 3-year average PE Ratio for Galapagos N.V. (GLPG)?

What is the 5-year average PE Ratio for Galapagos N.V. (GLPG)?

How does the current PE Ratio for Galapagos N.V. (GLPG) compare to its historical average?